Dyne Therapeutics, Inc. (DYN) Form 424B5 — Jul 22, 2026
Dyne Therapeutics is offering 18,300,000 shares of common stock at a public offering price of $20.50 per share, generating approximately $375.2 million in gross proceeds. Underwriters have been granted a 30-day option to purchase an additional 2,745,000 shares to cover over-allotments. The pricing represents a discount to the last reported sale price of $23.83 on July 21, 2026. Net proceeds from the offering are expected to be approximately $352.1 million and will be used to advance the development of z-rostudirsen and z-basivarsen.
Key figures
- Greenshoe
- 2745000
- Gross Proceeds
- 375150000
- Offering Price
- 20.5
- Shares Offered
- 18300000
- Last sale price
- 23.83
- Dilution per share
- 13.87
- Proceeds before expenses
- 352641000
- Shares outstanding post offering
- 183831839
Price after filing
Close on the filing date to close N calendar days later (from $23.83). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.